{
    "id": "dbpedia_1144_3",
    "rank": 42,
    "data": {
        "url": "https://karger.com/dne/article/44/6/429/841574/Research-Progress-of-Collapse-Response-Mediator",
        "read_more_link": "",
        "language": "en",
        "title": "Research Progress of Collapse Response Mediator Proteins in Neurodegenerative Diseases",
        "top_image": "https://karger.silverchair-cdn.com/karger/content_public/journal/dne/issue/44/6/6/m_280986_cover.jpeg?Expires=1785297986&Signature=Xik-MLELPR6NQ6X5YQ8qW~N3EN4NMuNv73hVIURgABcSahgFEoDqIsEncvBC8g6xWf4w3ZE7G5vUV9im~WcLY-ylZCDq-Iby0XDeceW5VD4me-hjqTKE9ajN02w5ZPVKFdYpdLf6E8GRbzFKYIpYVqheFME9RetBcdJPIKkAoQ-VBDtorNki-5L39SrhS5neAtKJDf314Qg1YREI2MfFz424z7udb5eCfslpWbpV940BG5XnGPEe-UVGoE1mqgdLGKCa4S-JFUB5hG3m0xxGaZkDGdLi1zb8fgUig1~3T8O5zzEbm2UhSOtFdz6QUBpBsCgC536AfJ0P7PtzK~kzag__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
        "meta_img": "https://karger.silverchair-cdn.com/karger/content_public/journal/dne/issue/44/6/6/m_280986_cover.jpeg?Expires=1785297986&Signature=Xik-MLELPR6NQ6X5YQ8qW~N3EN4NMuNv73hVIURgABcSahgFEoDqIsEncvBC8g6xWf4w3ZE7G5vUV9im~WcLY-ylZCDq-Iby0XDeceW5VD4me-hjqTKE9ajN02w5ZPVKFdYpdLf6E8GRbzFKYIpYVqheFME9RetBcdJPIKkAoQ-VBDtorNki-5L39SrhS5neAtKJDf314Qg1YREI2MfFz424z7udb5eCfslpWbpV940BG5XnGPEe-UVGoE1mqgdLGKCa4S-JFUB5hG3m0xxGaZkDGdLi1zb8fgUig1~3T8O5zzEbm2UhSOtFdz6QUBpBsCgC536AfJ0P7PtzK~kzag__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
        "images": [
            "https://karger.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/Karger_RGB_neg.svg",
            "https://karger.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/Images/umbrella/Karger_RGB.svg",
            "https://karger.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/dne/DNE_logo-356792884.png",
            "https://karger.silverchair-cdn.com/karger/content_public/journal/dne/issue/44/6/6/m_280986_cover.jpeg?Expires=1726352283&Signature=2UpdJHR5BKUYLCKK4~6By9fh~yxtjOkhyNtGVAHT0vlLBIr2Z0AMHSUencttHsfky6j59vhCHTcvKLKSbV-6fdV4kB9Q5Qa6Yo8cWsw9okKNvStVaVFSPdoDldw1VXByep3D8fNn9eAGw92ugzGCne8qxbtEHJxNRSH2EZKBL3Zb2spKt8NILUub2QjLeptSAky2IGFTt2bsI5LPvSgl8UaoUJc3fNBNvSY7Ey6YXrZAWGs6U9RXNT8gOEP7AAVn3ZdY4~N3REy~sYcs1pEBbJGDJUpijBAACojD7uu~A5HBG3FZkFEpxfpPxwuNj1DojQCEjLWKilB8Cehi8NN5lw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
            "https://www.deepdyve.com/assets/images/deepdyve-link-button.svg",
            "https://karger.silverchair-cdn.com/ImageLibrary/umbrella/Karger_RGB_neg.svg?versionId=23030"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Qin, Kun",
            "Xu, Shaoye",
            "Han, Yu",
            "Wang, Songhao",
            "Yan, Jianguo",
            "Shao, Xiaoyun"
        ],
        "publish_date": "2023-02-14T00:00:00",
        "summary": "",
        "meta_description": "Abstract. Collapse response mediator proteins (CRMPs) are a family of cytoplasmic phosphorylated proteins, and the mechanism of action has always been the",
        "meta_lang": "en",
        "meta_favicon": "//karger.silverchair-cdn.com/Themes/Client/app/img/favicons/v-638552060564293753/apple-touch-icon.png",
        "meta_site_name": "Karger Publishers",
        "canonical_link": "https://karger.com/dne/article/44/6/429/841574/Research-Progress-of-Collapse-Response-Mediator",
        "text": "1.\n\nHuttlin\n\nEL\n\n,\n\nBruckner\n\nRJ\n\n,\n\nPaulo\n\nJA\n\n,\n\nCannon\n\nJR\n\n,\n\nTing\n\nL\n\n,\n\nBaltier\n\nK\n\n, .\n\nArchitecture of the human interactome defines protein communities and disease networks\n\n.\n\nNature\n\n.\n\n2017\n\n;\n\n545\n\n(\n\n7655\n\n):\n\n505\n\n–\n\n9\n\n.\n\n2.\n\nTurck\n\nCW\n\n,\n\nWebhofer\n\nC\n\n,\n\nNussbaumer\n\nM\n\n,\n\nTeplytska\n\nL\n\n,\n\nChen\n\nA\n\n,\n\nMaccarrone\n\nG\n\n, .\n\nStable isotope metabolic labeling suggests differential turnover of the DPYSL protein family\n\n.\n\nProteomics Clin Appl\n\n.\n\n2016\n\n;\n\n10\n\n(\n\n12\n\n):\n\n1269\n\n–\n\n72\n\n.\n\n3.\n\nRicard\n\nD\n\n,\n\nRogemond\n\nV\n\n,\n\nCharrier\n\nE\n\n,\n\nAguera\n\nM\n\n,\n\nBagnard\n\nD\n\n,\n\nBelin\n\nMF\n\n, .\n\nIsolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes\n\n.\n\nJ Neurosci\n\n.\n\n2001\n\n;\n\n21\n\n(\n\n18\n\n):\n\n7203\n\n–\n\n14\n\n.\n\n4.\n\nCharrier\n\nE\n\n,\n\nReibel\n\nS\n\n,\n\nRogemond\n\nV\n\n,\n\nAguera\n\nM\n\n,\n\nThomasset\n\nN\n\n,\n\nHonnorat\n\nJ\n\n.\n\nCollapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders\n\n.\n\nMol Neurobiol\n\n.\n\n2003\n\n;\n\n28\n\n(\n\n1\n\n):\n\n51\n\n–\n\n64\n\n.\n\n5.\n\nAuvergnon\n\nN\n\n,\n\nReibel\n\nS\n\n,\n\nTouret\n\nM\n\n,\n\nHonnorat\n\nJ\n\n,\n\nBaron\n\nT\n\n,\n\nGiraudon\n\nP\n\n, .\n\nAltered expression of CRMPs in the brain of bovine spongiform encephalopathy-infected mice during disease progression\n\n.\n\nBrain Res\n\n.\n\n2009\n\n;\n\n1261\n\n:\n\n1\n\n–\n\n6\n\n.\n\n6.\n\nBretin\n\nS\n\n,\n\nReibel\n\nS\n\n,\n\nCharrier\n\nE\n\n,\n\nMaus-Moatti\n\nM\n\n,\n\nAuvergnon\n\nN\n\n,\n\nThevenoux\n\nA\n\n, .\n\nDifferential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain\n\n.\n\nJ Comp Neurol\n\n.\n\n2005\n\n;\n\n486\n\n(\n\n1\n\n):\n\n1\n\n–\n\n17\n\n.\n\n7.\n\nFukata\n\nY\n\n,\n\nItoh\n\nTJ\n\n,\n\nKimura\n\nT\n\n,\n\nMénager\n\nC\n\n,\n\nNishimura\n\nT\n\n,\n\nShiromizu\n\nT\n\n, .\n\nCRMP-2 binds to tubulin heterodimers to promote microtubule assembly\n\n.\n\nNat Cell Biol\n\n.\n\n2002\n\n;\n\n4\n\n(\n\n8\n\n):\n\n583\n\n–\n\n91\n\n.\n\n8.\n\nYuasa-Kawada\n\nJ\n\n,\n\nSuzuki\n\nR\n\n,\n\nKano\n\nF\n\n,\n\nOhkawara\n\nT\n\n,\n\nMurata\n\nM\n\n,\n\nNoda\n\nM\n\n.\n\nAxonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization\n\n.\n\nEur J Neurosci\n\n.\n\n2003\n\n;\n\n17\n\n(\n\n11\n\n):\n\n2329\n\n–\n\n43\n\n.\n\n9.\n\nQuach\n\nTT\n\n,\n\nDuchemin\n\nAM\n\n,\n\nRogemond\n\nV\n\n,\n\nAguera\n\nM\n\n,\n\nHonnorat\n\nJ\n\n,\n\nBelin\n\nMF\n\n, .\n\nInvolvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons\n\n.\n\nMol Cell Neurosci\n\n.\n\n2004\n\n;\n\n25\n\n(\n\n3\n\n):\n\n433\n\n–\n\n43\n\n.\n\n10.\n\nKurnellas\n\nMP\n\n,\n\nLi\n\nH\n\n,\n\nJain\n\nMR\n\n,\n\nGiraud\n\nSN\n\n,\n\nNicot\n\nAB\n\n,\n\nRatnayake\n\nA\n\n, .\n\nReduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons\n\n.\n\nCell Death Differ\n\n.\n\n2010\n\n;\n\n17\n\n(\n\n9\n\n):\n\n1501\n\n–\n\n10\n\n.\n\n11.\n\nMinturn\n\nJE\n\n,\n\nFryer\n\nHJ\n\n,\n\nGeschwind\n\nDH\n\n,\n\nHockfield\n\nS\n\n.\n\nTOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth\n\n.\n\nJ Neurosci\n\n.\n\n1995\n\n;\n\n15\n\n(\n\n10\n\n):\n\n6757\n\n–\n\n66\n\n.\n\n12.\n\nGoshima\n\nY\n\n,\n\nNakamura\n\nF\n\n,\n\nStrittmatter\n\nP\n\n,\n\nStrittmatter\n\nSM\n\n.\n\nCollapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33\n\n.\n\nNature\n\n.\n\n1995\n\n;\n\n376\n\n(\n\n6540\n\n):\n\n509\n\n–\n\n14\n\n.\n\n13.\n\nZhang\n\nJN\n\n,\n\nKoch\n\nJC\n\n.\n\nCollapsin response mediator protein-2 plays a major protective role in acute axonal degeneration\n\n.\n\nNeural Regen Res\n\n.\n\n2017\n\n;\n\n12\n\n(\n\n5\n\n):\n\n692\n\n–\n\n5\n\n.\n\n14.\n\nByk\n\nT\n\n,\n\nDobransky\n\nT\n\n,\n\nCifuentes-Diaz\n\nC\n\n,\n\nSobel\n\nA\n\n.\n\nIdentification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product\n\n.\n\nJ Neurosci\n\n.\n\n1996\n\n;\n\n16\n\n(\n\n2\n\n):\n\n688\n\n–\n\n701\n\n.\n\n15.\n\nFukada\n\nM\n\n,\n\nWatakabe\n\nI\n\n,\n\nYuasa-Kawada\n\nJ\n\n,\n\nKawachi\n\nH\n\n,\n\nKuroiwa\n\nA\n\n,\n\nMatsuda\n\nY\n\n, .\n\nMolecular characterization of CRMP5, a novel member of the collapsin response mediator protein family\n\n.\n\nJ Biol Chem\n\n.\n\n2000\n\n;\n\n275\n\n(\n\n48\n\n):\n\n37957\n\n–\n\n65\n\n.\n\n16.\n\nDeo\n\nRC\n\n,\n\nSchmidt\n\nEF\n\n,\n\nElhabazi\n\nA\n\n,\n\nTogashi\n\nH\n\n,\n\nBurley\n\nSK\n\n,\n\nStrittmatter\n\nSM\n\n.\n\nStructural bases for CRMP function in plexin-dependent semaphorin3A signaling\n\n.\n\nEmbo J\n\n.\n\n2004\n\n;\n\n23\n\n(\n\n1\n\n):\n\n9\n\n–\n\n22\n\n.\n\n17.\n\nHensley\n\nK\n\n,\n\nVenkova\n\nK\n\n,\n\nChristov\n\nA\n\n,\n\nGunning\n\nW\n\n,\n\nPark\n\nJ\n\n.\n\nCollapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications\n\n.\n\nMol Neurobiol\n\n.\n\n2011\n\n;\n\n43\n\n(\n\n3\n\n):\n\n180\n\n–\n\n91\n\n.\n\n18.\n\nPetratos\n\nS\n\n,\n\nLee\n\nJY\n\n.\n\nStop CRMPing my style: a new competitive model of CRMP oligomerization\n\n.\n\nJ Neurochem\n\n.\n\n2013\n\n;\n\n125\n\n(\n\n6\n\n):\n\n800\n\n–\n\n2\n\n.\n\n19.\n\nInatome\n\nR\n\n,\n\nTsujimura\n\nT\n\n,\n\nHitomi\n\nT\n\n,\n\nMitsui\n\nN\n\n,\n\nHermann\n\nP\n\n,\n\nKuroda\n\nS\n\n, .\n\nIdentification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain\n\n.\n\nJ Biol Chem\n\n.\n\n2000\n\n;\n\n275\n\n(\n\n35\n\n):\n\n27291\n\n–\n\n302\n\n.\n\n20.\n\nWang\n\nLH\n\n,\n\nStrittmatter\n\nSM\n\n.\n\nA family of rat CRMP genes is differentially expressed in the nervous system\n\n.\n\nJ Neurosci\n\n.\n\n1996\n\n;\n\n16\n\n(\n\n19\n\n):\n\n6197\n\n–\n\n207\n\n.\n\n21.\n\nHou\n\nST\n\n.\n\nThe regulatory and enzymatic functions of CRMPs in neuritogenesis, synaptic plasticity, and gene transcription\n\n.\n\nNeurochem Int\n\n.\n\n2020\n\n;\n\n139\n\n:\n\n104795\n\n.\n\n22.\n\nGuo\n\nGQ\n\n,\n\nZhang\n\nJF\n\n,\n\nXin\n\nL\n\n,\n\nChen\n\nJ\n\n,\n\nShen\n\nWZ\n\n,\n\nYuan\n\nL\n\n, .\n\nmRNA expression of Rho GTPase-related signaling molecules during rat hippocampal development\n\n.\n\nNeural Regen Res\n\n.\n\n2009\n\n;\n\n4\n\n(\n\n10\n\n):\n\n786\n\n–\n\n90\n\n.\n\n23.\n\nLin\n\nYS\n\n,\n\nLin\n\nYF\n\n,\n\nChen\n\nKC\n\n,\n\nYang\n\nYK\n\n,\n\nHsiao\n\nYH\n\n.\n\nCollapsin response mediator protein 5 (CRMP5) causes social deficits and accelerates memory loss in an animal model of Alzheimer’s disease\n\n.\n\nNeuropharmacology\n\n.\n\n2019\n\n;\n\n157\n\n:\n\n107673\n\n.\n\n24.\n\nMoutal\n\nA\n\n,\n\nWhite\n\nKA\n\n,\n\nChefdeville\n\nA\n\n,\n\nLaufmann\n\nRN\n\n,\n\nVitiello\n\nPF\n\n,\n\nFeinstein\n\nD\n\n, .\n\nDysregulation of CRMP2 post-translational modifications drive its pathological functions\n\n.\n\nMol Neurobiol\n\n.\n\n2019\n\n;\n\n56\n\n(\n\n10\n\n):\n\n6736\n\n–\n\n55\n\n.\n\n25.\n\nTsutiya\n\nA\n\n,\n\nOhtani-Kaneko\n\nR\n\n.\n\nPostnatal alteration of collapsin response mediator protein 4 mRNA expression in the mouse brain\n\n.\n\nJ Anat\n\n.\n\n2012\n\n;\n\n221\n\n(\n\n4\n\n):\n\n341\n\n–\n\n51\n\n.\n\n26.\n\nDubey\n\nD\n\n,\n\nLennon\n\nVA\n\n,\n\nGadoth\n\nA\n\n,\n\nPittock\n\nSJ\n\n,\n\nFlanagan\n\nEP\n\n,\n\nSchmeling\n\nJE\n\n, .\n\nAutoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases\n\n.\n\nNeurology\n\n.\n\n2018\n\n;\n\n90\n\n(\n\n2\n\n):\n\ne103\n\n–\n\ne10\n\n.\n\n27.\n\nLauzi\n\nJ\n\n,\n\nAnders\n\nF\n\n,\n\nLiu\n\nH\n\n,\n\nPfeiffer\n\nN\n\n,\n\nGrus\n\nF\n\n,\n\nThanos\n\nS\n\n, .\n\nNeuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma\n\n.\n\nPLoS One\n\n.\n\n2019\n\n;\n\n14\n\n(\n\n1\n\n):\n\ne0207190\n\n.\n\n29.\n\nTerenzio\n\nM\n\n,\n\nSchiavo\n\nG\n\n,\n\nFainzilber\n\nM\n\n.\n\nCompartmentalized signaling in neurons: from Cell biology to neuroscience\n\n.\n\nNeuron\n\n.\n\n2017\n\n;\n\n96\n\n(\n\n3\n\n):\n\n667\n\n–\n\n79\n\n.\n\n30.\n\nO'Toole\n\nM\n\n,\n\nLamoureux\n\nP\n\n,\n\nMiller\n\nKE\n\n.\n\nMeasurement of subcellular force generation in neurons\n\n.\n\nBiophys J\n\n.\n\n2015\n\n;\n\n108\n\n(\n\n5\n\n):\n\n1027\n\n–\n\n37\n\n.\n\n31.\n\nLi\n\nJN\n\n,\n\nJiang\n\nJD\n\n.\n\nBiological characteristics of microtubule and related drug research\n\n.\n\nYao Xue Xue Bao\n\n.\n\n2003\n\n;\n\n38\n\n(\n\n4\n\n):\n\n311\n\n–\n\n5\n\n.\n\n32.\n\nZhou\n\nFQ\n\n,\n\nSnider\n\nWD\n\n.\n\nIntracellular control of developmental and regenerative axon growth\n\n.\n\nPhilos Trans R Soc Lond B Biol Sci\n\n.\n\n2006\n\n;\n\n361\n\n(\n\n1473\n\n):\n\n1575\n\n–\n\n92\n\n.\n\n33.\n\nLi\n\nW\n\n,\n\nHerman\n\nRK\n\n,\n\nShaw\n\nJE\n\n.\n\nAnalysis of the caenorhabditis elegans axonal guidance and outgrowth gene unc-33\n\n.\n\nGenetics\n\n.\n\n1992\n\n;\n\n132\n\n(\n\n3\n\n):\n\n675\n\n–\n\n89\n\n.\n\n34.\n\nUchida\n\nY\n\n,\n\nOhshima\n\nT\n\n,\n\nYamashita\n\nN\n\n,\n\nOgawara\n\nM\n\n,\n\nSasaki\n\nY\n\n,\n\nNakamura\n\nF\n\n, .\n\nSemaphorin3A signaling mediated by fyn-dependent tyrosine phosphorylation of collapsin response mediator protein 2 at tyrosine 32\n\n.\n\nJ Biol Chem\n\n.\n\n2009\n\n;\n\n284\n\n(\n\n40\n\n):\n\n27393\n\n–\n\n401\n\n.\n\n35.\n\nYamashita\n\nN\n\n,\n\nMorita\n\nA\n\n,\n\nUchida\n\nY\n\n,\n\nNakamura\n\nF\n\n,\n\nUsui\n\nH\n\n,\n\nOhshima\n\nT\n\n, .\n\nRegulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1\n\n.\n\nJ Neurosci\n\n.\n\n2007\n\n;\n\n27\n\n(\n\n46\n\n):\n\n12546\n\n–\n\n54\n\n.\n\n36.\n\nQuach\n\nTT\n\n,\n\nMassicotte\n\nG\n\n,\n\nBelin\n\nMF\n\n,\n\nHonnorat\n\nJ\n\n,\n\nGlasper\n\nER\n\n,\n\nDevries\n\nAC\n\n, .\n\nCRMP3 is required for hippocampal CA1 dendritic organization and plasticity\n\n.\n\nFaseb J\n\n.\n\n2008\n\n;\n\n22\n\n(\n\n2\n\n):\n\n401\n\n–\n\n9\n\n.\n\n37.\n\nOhtani-Kaneko\n\nR\n\n.\n\nCrmp4-KO mice as an animal model for investigating certain phenotypes of autism spectrum disorders\n\n.\n\nInt J Mol Sci\n\n.\n\n2019\n\n;\n\n20\n\n(\n\n10\n\n):\n\n2485\n\n.\n\n38.\n\nNaudet\n\nN\n\n,\n\nMoutal\n\nA\n\n,\n\nVu\n\nHN\n\n,\n\nChounlamountri\n\nN\n\n,\n\nWatrin\n\nC\n\n,\n\nCavagna\n\nS\n\n, .\n\nTranscriptional regulation of CRMP5 controls neurite outgrowth through Sox5\n\n.\n\nCell Mol Life Sci\n\n.\n\n2018\n\n;\n\n75\n\n(\n\n1\n\n):\n\n67\n\n–\n\n79\n\n.\n\n39.\n\nKalpachidou\n\nT\n\n,\n\nSpiecker\n\nL\n\n,\n\nKress\n\nM\n\n,\n\nQuarta\n\nS\n\n.\n\nRho GTPases in the physiology and pathophysiology of peripheral sensory neurons\n\n.\n\nCells\n\n.\n\n2019\n\n;\n\n8\n\n(\n\n6\n\n):\n\n591\n\n.\n\n40.\n\nArimura\n\nN\n\n,\n\nMenager\n\nC\n\n,\n\nFukata\n\nY\n\n,\n\nKaibuchi\n\nK\n\n.\n\nRole of CRMP-2 in neuronal polarity\n\n.\n\nJ Neurobiol\n\n.\n\n2004\n\n;\n\n58\n\n(\n\n1\n\n):\n\n34\n\n–\n\n47\n\n.\n\n41.\n\nYamashita\n\nN\n\n.\n\nRetrograde signaling via axonal transport through signaling endosomes\n\n.\n\nJ Pharmacol Sci\n\n.\n\n2019\n\n;\n\n141\n\n(\n\n2\n\n):\n\n91\n\n–\n\n6\n\n.\n\n42.\n\nKawashima\n\nT\n\n,\n\nJitsuki-Takahashi\n\nA\n\n,\n\nTakizawa\n\nK\n\n,\n\nJitsuki\n\nS\n\n,\n\nTakahashi\n\nT\n\n,\n\nOhshima\n\nT\n\n, .\n\nPhosphorylation of collapsin response mediator protein 1 (CRMP1) at tyrosine 504 residue regulates semaphorin 3A-induced cortical dendritic growth\n\n.\n\nJ Neurochem\n\n.\n\n2021\n\n;\n\n157\n\n(\n\n4\n\n):\n\n1207\n\n–\n\n21\n\n.\n\n43.\n\nJiang\n\nT\n\n,\n\nZhang\n\nGW\n\n,\n\nLiang\n\nYZ\n\n,\n\nCai\n\nZB\n\n,\n\nLiang\n\nZ\n\n,\n\nLin\n\nHS\n\n, .\n\nPlexinA3 interacts with CRMP2 to mediate sema3A signalling during dendritic growth in cultured cerebellar granule neurons\n\n.\n\nNeuroscience\n\n.\n\n2020\n\n;\n\n434\n\n:\n\n83\n\n–\n\n92\n\n.\n\n44.\n\nRippin\n\nI\n\n,\n\nEldar-Finkelman\n\nH\n\n.\n\nMechanisms and therapeutic implications of GSK-3 in treating neurodegeneration\n\n.\n\nCells\n\n.\n\n2021\n\n;\n\n10\n\n(\n\n2\n\n):\n\n262\n\n.\n\n45.\n\nLin\n\nXH\n\n,\n\nChen\n\nHB\n\n,\n\nChen\n\nML\n\n,\n\nLi\n\nT\n\n,\n\nLai\n\nYX\n\n,\n\nLin\n\nLZ\n\n, .\n\nBone marrow-derived mesenchymal stem cells improve post-ischemia neurological function in rats via the PI3K/AKT/GSK-3β/CRMP-2 pathway\n\n.\n\nMol Cell Biochem\n\n.\n\n2021\n\n;\n\n476\n\n(\n\n5\n\n):\n\n2193\n\n–\n\n201\n\n.\n\n46.\n\nFan\n\nLY\n\n,\n\nMao\n\nCY\n\n,\n\nHu\n\nXC\n\n,\n\nZhang\n\nS\n\n,\n\nYang\n\nZH\n\n,\n\nHu\n\nZW\n\n, .\n\nNew insights into the pathogenesis of alzheimer’s disease\n\n.\n\nFront Neurol\n\n.\n\n2019\n\n;\n\n10\n\n:\n\n1312\n\n.\n\n47.\n\nHarari\n\nO\n\n,\n\nCruchaga\n\nC\n\n,\n\nKauwe\n\nJS\n\n,\n\nAinscough\n\nBJ\n\n,\n\nBales\n\nK\n\n,\n\nPickering\n\nEH\n\n, .\n\nPhosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer’s disease in multiplex immunoassay panels of cerebrospinal fluid\n\n.\n\nBiol Psychiatry\n\n.\n\n2014\n\n;\n\n75\n\n(\n\n9\n\n):\n\n723\n\n–\n\n31\n\n.\n\n48.\n\nLawal\n\nMF\n\n,\n\nOlotu\n\nFA\n\n,\n\nAgoni\n\nC\n\n,\n\nSoliman\n\nME\n\n.\n\nExploring the C-terminal tail dynamics: structural and molecular perspectives into the therapeutic activities of novel CRMP-2 inhibitors, naringenin and naringenin-7-O-glucuronide, in the treatment of Alzheimer’s disease\n\n.\n\nChem Biodivers\n\n.\n\n2018\n\n;\n\n15\n\n(\n\n12\n\n):\n\ne1800437\n\n.\n\n49.\n\nMokhtar\n\nSH\n\n,\n\nKim\n\nMJ\n\n,\n\nMagee\n\nKA\n\n,\n\nAui\n\nPM\n\n,\n\nThomas\n\nS\n\n,\n\nBakhuraysah\n\nMM\n\n, .\n\nAmyloid-beta-dependent phosphorylation of collapsin response mediator protein-2 dissociates kinesin in Alzheimer’s disease\n\n.\n\nNeural Regen Res\n\n.\n\n2018\n\n;\n\n13\n\n(\n\n6\n\n):\n\n1066\n\n–\n\n80\n\n.\n\n50.\n\nNakamura\n\nH\n\n,\n\nTakahashi-Jitsuki\n\nA\n\n,\n\nMakihara\n\nH\n\n,\n\nAsano\n\nT\n\n,\n\nKimura\n\nY\n\n,\n\nNakabayashi\n\nJ\n\n, .\n\nProteome and behavioral alterations in phosphorylation-deficient mutant collapsin response mediator protein2 knock-in mice\n\n.\n\nNeurochem Int\n\n.\n\n2018\n\n;\n\n119\n\n:\n\n207\n\n–\n\n17\n\n.\n\n51.\n\nSveinbjornsdottir\n\nS\n\n.\n\nThe clinical symptoms of Parkinson’s disease\n\n.\n\nJ Neurochem\n\n.\n\n2016\n\n;\n\n139\n\n(\n\nSuppl 1\n\n):\n\n318\n\n–\n\n24\n\n.\n\n52.\n\nLi\n\nW\n\n,\n\nGoshima\n\nY\n\n,\n\nOhshima\n\nT\n\n.\n\nLoss of collapsin response mediator protein 4 attenuates 6-hydroxydopamine-induced impairments in a mouse model of Parkinson’s disease\n\n.\n\nNeurochem Res\n\n.\n\n2020\n\n;\n\n45\n\n(\n\n10\n\n):\n\n2286\n\n–\n\n301\n\n.\n\n53.\n\nFang\n\nW\n\n,\n\nGao\n\nGD\n\n,\n\nZhao\n\nH\n\n,\n\nXia\n\nY\n\n,\n\nGuo\n\nX\n\n,\n\nLi\n\nN\n\n, .\n\nRole of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity\n\n.\n\nBrain Res\n\n.\n\n2015\n\n;\n\n1602\n\n:\n\n9\n\n–\n\n19\n\n.\n\n54.\n\nXu\n\nL\n\n,\n\nChen\n\nL\n\n,\n\nWang\n\nSF\n\n,\n\nFeng\n\nJN\n\n,\n\nLiu\n\nL\n\n,\n\nLiu\n\nGZ\n\n, .\n\nIncidence and prevalence of amyotrophic lateral sclerosis in urban China: a National Population-Based Study\n\n.\n\nJ Neurol Neurosurg Psychiatry\n\n.\n\n2020\n\n;\n\n91\n\n(\n\n5\n\n):\n\n520\n\n–\n\n5\n\n.\n\n55.\n\nNumata-Uematsu\n\nY\n\n,\n\nWakatsuki\n\nS\n\n,\n\nNagano\n\nS\n\n,\n\nShibata\n\nM\n\n,\n\nSakai\n\nK\n\n,\n\nIchinohe\n\nN\n\n, .\n\nInhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A\n\n.\n\nNeurosci Res\n\n.\n\n2019\n\n;\n\n139\n\n:\n\n63\n\n–\n\n8\n\n.\n\n56.\n\nMaimon\n\nR\n\n,\n\nAnkol\n\nL\n\n,\n\nGradus Pery\n\nT\n\n,\n\nAltman\n\nT\n\n,\n\nIonescu\n\nA\n\n,\n\nWeissova\n\nR\n\n, .\n\nA CRMP4-dependent retrograde axon-to-soma death signal in amyotrophic lateral sclerosis\n\n.\n\nEmbo J\n\n.\n\n2021\n\n;\n\n40\n\n(\n\n17\n\n):\n\ne107586\n\n.\n\n57.\n\nKlockgether\n\nT\n\n,\n\nMariotti\n\nC\n\n,\n\nPaulson\n\nHL\n\n.\n\nSpinocerebellar ataxia\n\n.\n\nNat Rev Dis Primers\n\n.\n\n2019\n\n;\n\n5\n\n(\n\n1\n\n):\n\n24\n\n.\n\n58.\n\nWinkler\n\nSC\n\n,\n\nShimobayashi\n\nE\n\n,\n\nKapfhammer\n\nJP\n\n.\n\nPKCγ-mediated phosphorylation of CRMP2 regulates dendritic outgrowth in cerebellar purkinje cells\n\n.\n\nMol Neurobiol\n\n.\n\n2020\n\n;\n\n57\n\n(\n\n12\n\n):\n\n5150\n\n–\n\n66\n\n.\n\n59.\n\nElshahabi\n\nA\n\n,\n\nKlamer\n\nS\n\n,\n\nSahib\n\nAK\n\n,\n\nLerche\n\nH\n\n,\n\nBraun\n\nC\n\n,\n\nFocke\n\nNK\n\n.\n\nMagnetoencephalography reveals a widespread increase in network connectivity in idiopathic/genetic generalized epilepsy\n\n.\n\nPLoS One\n\n.\n\n2015\n\n;\n\n10\n\n(\n\n9\n\n):\n\ne0138119\n\n.\n\n60.\n\nWilson\n\nSM\n\n,\n\nMoutal\n\nA\n\n,\n\nMelemedjian\n\nOK\n\n,\n\nWang\n\nY\n\n,\n\nJu\n\nW\n\n,\n\nFrançois-Moutal\n\nL\n\n, .\n\nThe functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth\n\n.\n\nFront Cell Neurosci\n\n.\n\n2014\n\n;\n\n8\n\n:\n\n196\n\n.\n\n61.\n\nNirwan\n\nN\n\n,\n\nSiraj\n\nF\n\n,\n\nVohora\n\nD\n\n.\n\nInverted-U response of lacosamide on pilocarpine-induced status epilepticus and oxidative stress in C57BL/6 mice is independent of hippocampal collapsin response mediator protein-2\n\n.\n\nEpilepsy Res\n\n.\n\n2018\n\n;\n\n145\n\n:\n\n93\n\n–\n\n101\n\n.\n\n62.\n\nQin\n\nL\n\n,\n\nLiu\n\nX\n\n,\n\nLiu\n\nSY\n\n,\n\nLiu\n\nY\n\n,\n\nYang\n\nYX\n\n,\n\nYang\n\nH\n\n, .\n\nDifferentially expressed proteins underlying childhood cortical dysplasia with epilepsy identified by iTRAQ proteomic profiling\n\n.\n\nPLoS One\n\n.\n\n2017\n\n;\n\n12\n\n(\n\n2\n\n):\n\ne0172214\n\n.\n\n63.\n\nFurukawa\n\nA\n\n,\n\nKakita\n\nA\n\n,\n\nChiba\n\nY\n\n,\n\nKitaura\n\nH\n\n,\n\nFujii\n\nY\n\n,\n\nFukuda\n\nM\n\n, .\n\nProteomic profile differentiating between mesial temporal lobe epilepsy with and without hippocampal sclerosis\n\n.\n\nEpilepsy Res\n\n.\n\n2020\n\n;\n\n168\n\n:\n\n106502\n\n.\n\n64.\n\nLiu\n\nXL\n\n,\n\nFeng\n\nZT\n\n,\n\nDu\n\nLP\n\n,\n\nHuang\n\nYG\n\n,\n\nGe\n\nJW\n\n,\n\nDeng\n\nYH\n\n, .\n\nThe potential role of MicroRNA-124 in cerebral ischemia injury\n\n.\n\nInt J Mol Sci\n\n.\n\n2019\n\n;\n\n21\n\n(\n\n1\n\n):\n\n120\n\n.\n\n65.\n\nYao\n\nY\n\n,\n\nJi\n\nYS\n\n,\n\nRen\n\nJH\n\n,\n\nLiu\n\nHY\n\n,\n\nKhanna\n\nR\n\n,\n\nSun\n\nL\n\n.\n\nInhibition of autophagy by CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKKβ/AMPK/mTOR pathway contributes to ischemic postconditioning-induced neuroprotection against cerebral ischemia-reperfusion injury\n\n.\n\nMol Brain\n\n.\n\n2021\n\n;\n\n14\n\n(\n\n1\n\n):\n\n123\n\n.\n\n67.\n\nNagai\n\nJ\n\n,\n\nBaba\n\nR\n\n,\n\nOhshima\n\nT\n\n.\n\nCRMPs function in neurons and glial cells: potential therapeutic targets for neurodegenerative diseases and CNS injury\n\n.\n\nMol Neurobiol\n\n.\n\n2017\n\n;\n\n54\n\n(\n\n6\n\n):\n\n4243\n\n–\n\n56\n\n.\n\n68.\n\nHe\n\nL\n\n,\n\nKooistra\n\nR\n\n,\n\nDas\n\nR\n\n,\n\nOudejans\n\nE\n\n,\n\nvan Leen\n\nE\n\n,\n\nZiegler\n\nJ\n\n, .\n\nCortical anchoring of the microtubule cytoskeleton is essential for neuron polarity\n\n.\n\nElife\n\n.\n\n2020\n\n;\n\n9\n\n:\n\ne55111\n\n.\n\n69.\n\nChen\n\nYC\n\n,\n\nHuang\n\nHR\n\n,\n\nHsu\n\nCH\n\n,\n\nOu\n\nCY\n\n.\n\nCRMP/UNC-33 organizes microtubule bundles for KIF5-mediated mitochondrial distribution to axon\n\n.\n\nPLoS Genet\n\n.\n\n2021\n\n;\n\n17\n\n(\n\n2\n\n):\n\ne1009360\n\n.\n\n70.\n\nLiao\n\nZ\n\n,\n\nLi\n\nJ\n\n,\n\nMiao\n\nL\n\n,\n\nHuang\n\nZ\n\n,\n\nHuang\n\nW\n\n,\n\nLiu\n\nY\n\n, .\n\nInhibition of RhoA activity does not rescue synaptic development abnormalities and long-term cognitive impairment after sevoflurane exposure\n\n.\n\nNeurochem Res\n\n.\n\n2021\n\n;\n\n46\n\n(\n\n3\n\n):\n\n468\n\n–\n\n81\n\n.\n\n71.\n\nLiu\n\nHH\n\n,\n\nJan\n\nYN\n\n.\n\nMechanisms of neurite repair\n\n.\n\nCurr Opin Neurobiol\n\n.\n\n2020\n\n;\n\n63\n\n:\n\n53\n\n–\n\n8\n\n."
    }
}